NDC 70710-1401-01 - CLOBETASOL PROPIONATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1401
- Requested NDC
- 70710-1401-01
- Package NDCs from labels
- 70710-1401-1, 70710-1401-2, 70710-1401-4, 70710-1401-3, 70710-1401-01
- Manufacturer
- Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited
- Effective date
- 2022-10-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CLOBETASOL - Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | Zydus Pharmaceuticals USA Inc. | Zydus Lifesciences Limited | 2022-10-05 | HUMAN PRESCRIPTION DRUG LABEL |
| CLOBETASOL PROPIONATE OINTMENT USP, 0.05% | Preferred Pharmaceuticals, Inc. | 2022-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1401-1 | CLOBETASOL PROPIONATE | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 70710-1401-1 | CLOBETASOL PROPIONATE | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 70710-1401-2 | CLOBETASOL PROPIONATE | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 70710-1401-2 | CLOBETASOL PROPIONATE | 30 g in 1 TUBE | OINTMENT | 30 | 6 | |
| 70710-1401-3 | CLOBETASOL PROPIONATE | 60 g in 1 TUBE | OINTMENT | 60 | 6 | |
| 70710-1401-3 | CLOBETASOL PROPIONATE | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 70710-1401-4 | CLOBETASOL PROPIONATE | 45 g in 1 TUBE | OINTMENT | 45 | 6 | |
| 70710-1401-4 | CLOBETASOL PROPIONATE | 1 in 1 CARTON | OINTMENT | 1 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1401 | CLOBETASOL PROPIONATE OINTMENT [ZYDUS PHARMACEUTICALS USA INC.] | 6 | Current NDC, Legacy NDC, 8 package rows | 20221007_98a25409-e84e-452b-8dc5-ad87842398e1.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70710-1401-1 | GM - Gram | 70710-1401 | dca331a7-bcc8-4f19-a9f3-51fed30ef500 | 1 | 2019-04-11 |
| 70710-1401-2 | GM - Gram | 70710-1401 | 2d156802-6d97-4fa4-82fd-eefd8cfb2731 | 1 | 2019-04-11 |
| 70710-1401-3 | GM - Gram | 70710-1401 | abe4f473-b54e-44c6-b448-6ea1d8959a62 | 1 | 2019-04-11 |
| 70710-1401-4 | GM - Gram | 70710-1401 | 8d5330df-ae86-45ca-9c89-e40f20dda0ff | 1 | 2019-04-11 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Perfect 10 Soothing Recovery | PETROLATUM | Topiderm, Inc. | e3a4f038-d084-4d77-bd35-13f41856a615 | 2025-04-30 | Warnings | 4T6H12BN9U |
| OraLabs ChapIce Original Petrolatum | PETROLATUM | OraLabs | 54729693-f0e2-48ad-881a-a07986ed823b | 2025-04-30 | Warnings | 4T6H12BN9U |
| Sunfrog Ultra SPF 30 Lip Balm | OCTINOXATE, OCTOCRYLENE, OXYBENZONE, OCTISALATE, PETROLEUM JELLY | OraLabs | 61299626-bf60-40e8-a2d3-4d4a99d8d15c | 2025-04-30 | Warnings | 4T6H12BN9U |
| ChapIce Moisture SPF 15 Lip Balm | OXYBENZONE, OCTINOXATE, PETROLATUM | Navajo Manufacturing Company Inc. | 60ce1a8c-180a-161e-e053-2991aa0ae981 | 2025-04-29 | Warnings | 4T6H12BN9U |
| OraLabs ChapIce Cherry Petrolatum | PETROLATUM | OraLabs | f0d9d01e-bfdf-4e33-abfb-f683d414d808 | 2025-04-29 | Warnings | 4T6H12BN9U |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Limited | 6fc0d1ac-f357-4038-8004-263bfaed4eaf | 2025-04-25 | Warnings, Adverse reactions | 779619577M |
| SPF 45 - Lip Balm | AVOBENZONE, HOMOSALATE, OCTINOXATE, OCTISALATE, PETROLATUM | OraLabs | afd10abe-1e8b-4df8-9d8c-ef15266c510c | 2025-04-22 | Warnings | 4T6H12BN9U |
| OraLabs SPF 15 Lip Balm | AVOBENZONE, OCTINOXATE, PETROLATUM | OraLabs | 3ac8569f-4b11-4536-8919-234f79bbd7fc | 2025-04-22 | Warnings | 4T6H12BN9U |
| ChapIce SPF 30 Lip Balm | AVOBENZONE, OCTISALATE, HOMOSALATE, PETROLATUM | OraLabs | c7094485-a19f-41b7-88b8-d6d472adbff1 | 2025-04-22 | Warnings | 4T6H12BN9U |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Eyenovia, Inc. | 7687c980-7006-4222-80b9-c32773772d3e | 2025-04-16 | Warnings, Adverse reactions | 779619577M |
| Petroleum Jelly | PETROLATUM | Walgreens | 69bdd508-7c33-42c5-9a08-e56cf3eaebf3 | 2025-04-11 | Warnings | 4T6H12BN9U |
| clobetasol propionate | CLOBETASOL PROPIONATE | Bryant Ranch Prepack | 2d0b48d9-dbfb-4265-b73b-07faf217ae6e | 2025-04-02 | Warnings, Adverse reactions | 779619577M |
| hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Bionpharma Inc. | 1790da99-2a22-e2a2-e063-6394a90ac36f | 2025-03-31 | Warnings | 4T6H12BN9U |
| Vaseline | BABY HEALING JELLY | Conopco Inc. d/b/a Unilever | bca3176f-86fe-5969-e053-2995a90a2419 | 2025-03-31 | Warnings | 4T6H12BN9U |
| Clobetasol Propionate | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Inc. | fc3ac7b5-0cd5-4d31-97e4-b01c0f715835 | 2025-03-28 | Adverse reactions | 861448 779619577M |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Limited | a4f74fc7-d2f6-4cf2-9cc5-60078bde55a7 | 2025-03-26 | Adverse reactions | 779619577M |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Limited | 46bda1db-c2eb-461a-bcd0-dfdb6c7f542d | 2025-03-18 | Adverse reactions | 779619577M |
| CLOBETASOL PROPIONATE | CLOBETASOL PROPIONATE | Alembic Pharmaceuticals Limited | 2b7f0643-679c-4586-a3a0-31eae4a36f19 | 2025-03-18 | Warnings, Adverse reactions | 779619577M |
| Winco Medicated Lip Balm | PETROLATUM | Winco | c81cd9f7-f23a-4873-8542-1926497d39ce | 2025-03-07 | Warnings | 4T6H12BN9U |
| AD Skin Protectant | AD SKIN PROTECTANT | WellSpring Pharmaceutical Corporation | d26f1312-2e1b-4106-bc48-a336d4e034ad | 2025-03-07 | Warnings | 4T6H12BN9U |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.